• Japanese
  • Korean
  • Chinese
Cover Image

Pulmonary Embolism Global Clinical Trials Review, H2, 2013

GlobalData's clinical trial report, "Pulmonary Embolism Global Clinical Trials Review, H2, 2013" provides data on the Pulmonary Embolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Embolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Embolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 5
  • List of Figures 6
  • Introduction 7
  • Pulmonary Embolism 7
  • Report Guidance 7
  • Clinical Trials by Region 8
  • Clinical Trials by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by BRIC Nations 16
  • Clinical Trials by G7 Nations 17
  • Clinical Trials in G7 Nations by Trial Status 18
  • Clinical Trials by E7 Nations 19
  • Clinical Trials in E7 Nations by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Unaccomplished Trials of Pulmonary Embolism 24
  • Subjects Recruited Over a Period of Time 27
  • Prominent Sponsors 28
  • Top Companies Participating in Pulmonary Embolism Therapeutics Clinical Trials 30
  • Prominent Drug Comparison 32
  • Clinical Trial Profiles 33
  • Clinical Trial Overview of Top Companies 33
  • Bayer AG 33
  • Clinical Trial Overview of Bayer AG 33
  • Bristol-Myers Squibb Company 34
  • Clinical Trial Overview of Bristol-Myers Squibb Company 34
  • GlaxoSmithKline plc 35
  • Clinical Trial Overview of GlaxoSmithKline plc 35
  • AGEN Biomedical Limited 36
  • Clinical Trial Overview of AGEN Biomedical Limited 36
  • AstraZeneca PLC 37
  • Clinical Trial Overview of AstraZeneca PLC 37
  • Sanofi 38
  • Clinical Trial Overview of Sanofi 38
  • EKOS Corporation 39
  • Clinical Trial Overview of EKOS Corporation 39
  • Daiichi Sankyo Company, Limited 40
  • Clinical Trial Overview of Daiichi Sankyo Company, Limited 40
  • Pfizer Inc. 41
  • Clinical Trial Overview of Pfizer Inc. 41
  • Daiichi Sankyo Europe GmbH 42
  • Clinical Trial Overview of Daiichi Sankyo Europe GmbH 42
  • Astellas Pharma Europe B.V. 43
  • Clinical Trial Overview of Astellas Pharma Europe B.V. 43
  • Daiichi Sankyo, Inc. 44
  • Clinical Trial Overview of Daiichi Sankyo, Inc. 44
  • Eisai Inc. 45
  • Clinical Trial Overview of Eisai Inc. 45
  • Portola Pharmaceuticals, Inc. 46
  • Clinical Trial Overview of Portola Pharmaceuticals, Inc. 46
  • Diagnostica Stago SAS 47
  • Clinical Trial Overview of Diagnostica Stago SAS 47
  • LEO Pharma A/S 48
  • Clinical Trial Overview of LEO Pharma A/S 48
  • Novartis AG 49
  • Clinical Trial Overview of Novartis AG 49
  • MCS Medical Compression Systems (DBN) Ltd. 50
  • Clinical Trial Overview of MCS Medical Compression Systems (DBN) Ltd. 50
  • Eli Lilly and Company 51
  • Clinical Trial Overview of Eli Lilly and Company 51
  • Thermo Fisher Scientific Inc. 52
  • Clinical Trial Overview of Thermo Fisher Scientific Inc. 52
  • Clinical Trial Overview of Top Institutes / Government 53
  • Leiden University Medical Center 53
  • Clinical Trial Overview of Leiden University Medical Center 53
  • Brigham and Women's Hospital 54
  • Clinical Trial Overview of Brigham and Women's Hospital 54
  • Beijing Chao Yang Hospital 55
  • Clinical Trial Overview of Beijing Chao Yang Hospital 55
  • Hamilton Health Sciences 56
  • Clinical Trial Overview of Hamilton Health Sciences 56
  • University of Perugia 57
  • Clinical Trial Overview of University of Perugia 57
  • Ottawa Hospital Research Institute 58
  • Clinical Trial Overview of Ottawa Hospital Research Institute 58
  • Assistance Publique - Hopitaux de Paris 59
  • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 59
  • National Heart, Lung, and Blood Institute 60
  • Clinical Trial Overview of National Heart, Lung, and Blood Institute 60
  • St. Orsola Hospital 61
  • Clinical Trial Overview of St. Orsola Hospital 61
  • University Hospital, Brest 62
  • Clinical Trial Overview of University Hospital, Brest 62
  • University of Pittsburgh 63
  • Clinical Trial Overview of University of Pittsburgh 63
  • Carolinas Healthcare System 64
  • Clinical Trial Overview of Carolinas Healthcare System 64
  • University Hospital, Grenoble 65
  • Clinical Trial Overview of University Hospital, Grenoble 65
  • McMaster University 66
  • Clinical Trial Overview of McMaster University 66
  • The Cleveland Clinic 67
  • Clinical Trial Overview of The Cleveland Clinic 67
  • St. Joseph's Healthcare Hamilton 68
  • Clinical Trial Overview of St. Joseph's Healthcare Hamilton 68
  • Ludwig-Maximilians-Universitat Munich 69
  • Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 69
  • William Beaumont Hospitals 70
  • Clinical Trial Overview of William Beaumont Hospitals 70
  • Academic Medical Centre 71
  • Clinical Trial Overview of Academic Medical Centre 71
  • Chinese PLA General Hospital 72
  • Clinical Trial Overview of Chinese PLA General Hospital 72
  • Five Key Clinical Profiles 73

Appendix 215

  • Abbreviations 215
  • Definitions 215
  • Research Methodology 216
  • Secondary Research 216
  • About GlobalData 217
  • Contact Us 217
  • Disclaimer 217
  • Source 218

List of Tables

List of Tables

  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Pulmonary Embolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
  • Pulmonary Embolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
  • Pulmonary Embolism Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
  • Pulmonary Embolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
  • Pulmonary Embolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
  • Pulmonary Embolism Therapeutics Clinical Trials, BRIC Countries, 2013* 16
  • Pulmonary Embolism Therapeutics Clinical Trials, G7 Countries, 2013* 17
  • Pulmonary Embolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Pulmonary Embolism Therapeutics Clinical Trials, E7 Countries, 2013* 19
  • Pulmonary Embolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Pulmonary Embolism Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
  • Pulmonary Embolism Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
  • Pulmonary Embolism Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 33
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 34
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 35
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AGEN Biomedical Limited, 2013* 36
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 37
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 38
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by EKOS Corporation, 2013* 39
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 40
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 41
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Europe GmbH, 2013* 42
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Europe B.V., 2013* 43
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2013* 44
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2013* 45
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Portola Pharmaceuticals, Inc., 2013* 46
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Diagnostica Stago SAS, 2013* 47
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2013* 48
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 49
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by MCS Medical Compression Systems (DBN) Ltd., 2013* 50
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 51
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Thermo Fisher Scientific Inc., 2013* 52
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 53
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 54
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao Yang Hospital, 2013* 55
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2013* 56
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Perugia, 2013* 57
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2013* 58
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 59
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 60
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2013* 61
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Brest, 2013* 62
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 63
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Carolinas Healthcare System, 2013* 64
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2013* 65
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013* 66
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 67
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Healthcare Hamilton, 2013* 68
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2013* 69
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by William Beaumont Hospitals, 2013* 70
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 71
  • Pulmonary Embolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese PLA General Hospital, 2013* 72

List of Figures

List of Figures

  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Pulmonary Embolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
  • Pulmonary Embolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
  • Pulmonary Embolism Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
  • Pulmonary Embolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
  • Pulmonary Embolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
  • Pulmonary Embolism Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
  • Pulmonary Embolism Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
  • Pulmonary Embolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Pulmonary Embolism Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
  • Pulmonary Embolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
  • Pulmonary Embolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
  • Pulmonary Embolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • GlobalData Methodology 216
Show More
Pricing
Get Notified
Email me when related reports are published